Skip to content

An exploratory study of the effects of continuous intake of high gamma PGA natto on physique and glucose and lipid metabolism.

An exploratory study of the effects of continuous intake of high gamma PGA natto on physique and glucose and lipid metabolism. - A pilot study of high gamma PGA natto continuous intake

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000033528
Enrollment
30
Registered
2018-07-30
Start date
2018-08-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Low gamma PGA natto. 40g per day for 6weeks. High gamma PGA natto. 40g per day for 6weeks.

Sponsors

Fuculty of Medicine University of Tsukuba
Lead Sponsor
1.Takanofoods Co.,Ltd. 2.Industrial technology innovation center of Ibaraki prefecture. 3.National agriculture and food research organization, food research institute.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.BMI not less than 23.0 kg/m2, under 25.0 kg/m2 2. Capable of giving informed consent.

Exclusion criteria

Exclusion criteria: 1. Fasting blood glucose not less than 126 mg/dL and/or HbA1c not less than 6.5% 2. TG not less than 200 mg/dL and/or LDL-C not less than 160 mg/dL 3. SBP not less than 160 mmHg and/or DBP not less than 100 mmHg 4. Subjects who are treated for diabetes and/or hyperlipidemia and/or hypertension. 5. Subjects who are habitually taking supplement (including "food for specified health use", and "foods with function claims") that include lactic acid bacterium, bifidobacteria, oligosaccharide, dietary fiber, and ingredients of natto. 6. Subjects who are enrollment in another interventional study 7. Subjects who were recognized unsuitable for this study by the Investigator.

Design outcomes

Primary

MeasureTime frame
Blood lipid level(TG, HDL-C, LDL-C, TC) at 12 weeks.

Secondary

MeasureTime frame
1.Body weight, Waist circumference 2.Blood pressure 3.Biomarkers(fasting blood gulcose, HbA1c, insulin, C-peptide, AST, ALT, amma GTP, BUN, Cr, UA, FFA, TP, Alb) 4.Amount of test meal consumption 5.Defecation frequency 6.Organoleptic evaluation

Countries

Japan

Contacts

Public ContactKoichi Hashimoto

University of Tsukuba, Faculty of Medicene Clinical and Translational Research Methodology

koichi.hashimoto@md.tsukuba.ac.jp029-853-3064

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026